Literature DB >> 8902605

Genomic imprinting: significance in development and diseases and the molecular mechanisms.

M Nakao1, H Sasaki.   

Abstract

Certain mammalian genes are expressed exclusively from either the paternal or the maternal chromosome because of a differential marking process that occurs during gametogenesis. This epigenetic marking is called genomic imprinting. Monoallelic expression of imprinted genes is responsible for the inability of uniparental mammalian embryos to develop normally and for the abnormal phenotypes observed with particular chromosomal disomies. Many of the imprinted genes identified to date are involved in the regulation of cell proliferation and differentiation and, together with other pieces of evidence, they are suggested to play a role in tumorigenesis. Here we discuss how imprinted genes cause diseases and tumors and summarize the recent advances of studies on the molecular basis of this epigenetic phenomenon. In particular, we focus on two well-characterized imprinted chromosomal regions, namely the human Prader-Willi/Angelman syndrome region and the mouse INS2/IGF2/H19 region. The correlations between the differential gene activity and the changes in DNA methylation, higher order chromatin structure and replication timing, will shed light on gene regulation at the level of the chromosomal domain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902605     DOI: 10.1093/oxfordjournals.jbchem.a021434

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Screening for imprinted genes by allelic message display: identification of a paternally expressed gene impact on mouse chromosome 18.

Authors:  Y Hagiwara; M Hirai; K Nishiyama; I Kanazawa; T Ueda; Y Sakaki; T Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.

Authors:  Katsue Sunahori; Yuang-Taung Juang; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

3.  Development and imprinted gene expression in uniparental preimplantation mouse embryos in vitro.

Authors:  Minhua Hu; Li-Chi TuanMu; Hengxi Wei; Fenglei Gao; Li Li; Shouquan Zhang
Journal:  Mol Biol Rep       Date:  2014-10-01       Impact factor: 2.316

4.  Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

Authors:  Sarika U Peters; Lynne M Bird; Virginia Kimonis; Daniel G Glaze; Lina M Shinawi; Terry Jo Bichell; Rene Barbieri-Welge; Mark Nespeca; Irina Anselm; Susan Waisbren; Erica Sanborn; Qin Sun; William E O'Brien; Arthur L Beaudet; Carlos A Bacino
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

5.  Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts.

Authors:  Mark A Casillas; Nadejda Lopatina; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

6.  Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma.

Authors:  Guo-Fang Guan; De-Jun Zhang; Lian-Ji Wen; Ding Xin; Yan Liu; Duo-Jiao Yu; Kai Su; Lin Zhu; Ying-Yuan Guo; Ke Wang
Journal:  Int J Med Sci       Date:  2016-11-09       Impact factor: 3.738

7.  miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Authors:  Wan Li; Jie Yi; Xiangjin Zheng; Shiwei Liu; Weiqi Fu; Liwen Ren; Li Li; Dave S B Hoon; Jinhua Wang; Guanhua Du
Journal:  Clin Epigenetics       Date:  2018-05-16       Impact factor: 7.259

8.  miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.

Authors:  Zhiheng Chen; Shaojun Liu; Li Tian; Minghao Wu; Feiyan Ai; Wuliang Tang; Lian Zhao; Juan Ding; Liyang Zhang; Anliu Tang
Journal:  Oncotarget       Date:  2015-11-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.